Poly-γ-glutamic acid (γ-PGA) is a valuable biopolymer with diverse industrial applications, produced naturally by several Bacillus species. The dairy environment is an under-explored niche for identifying efficient, food-grade γ-PGA producers. In this study, four legacy dairy-derived Bacillus licheniformis strains: DPC3803, DPC6338, DPC6339, and DPC6340, producing high γ-PGA titres were examined using whole genome sequencing (WGS) and comparative genomic analysis to evaluate their suitability for future industrial applications. The genomes ranged from 4.19 to 4.29 Mb with an average GC content of 45.8–46.2%. Pangenome analysis of the four strains, together with 51 publicly available B. licheniformis genomes, identified 12,415 gene clusters, of which 18.9% and 81.1% were core and accessory genes respectively. Average nucleotide identity (ANI) analysis demonstrated >99% sequence identity among all 55 B. licheniformis genomes, despite their isolation from diverse environments, indicating strong genomic conservation within the species. Experimental validation confirmed γ-PGA production by all four strains, with maximum titres (g/L) of 43.27 ± 1.49, 59.54 ± 4.33, 27.93 ± 1.87, and 47.74 ± 0.19 for DPC3803, DPC6338, DPC6339, and DPC6340, respectively. Genomic screening revealed multiple γ-PGA metabolism and CAZyme-encoding genes, as well as unique secondary metabolite clusters with potential antimicrobial activity. Although no plasmids or virulence factors were detected, twenty-one prophages were identified, sharing no significant homology with known cultivated phages, and a single β-lactamase gene suggested intrinsic resistance to β-lactams. These findings highlight the genomic and functional potential of these dairy-derived B. licheniformis as efficient, food-grade candidates for industrial γ-PGA production.

BackgroundOrthodontic relapse is a frequent problem that many patients experience. Although orthodontic therapy has advanced, recurrence rates can still reach 90%. We undertook a study to look at the possibilities of laser bio-stimulation and stem cells because they have showed promising outcomes in lowering recurrence rates. ObjectivesOur objective was to analyze the effects of Low-level laser therapy (LLLT) and Mesenchymal stem cells (MSC) alone and collectively on the rate of orthodontic relapse in rats radiographically and histologically. MethodsRat maxillary central incisors were moved distally for two weeks. One week later, the incisors were retained. Animals (n = 40) were split into four groups. Control group (C); laser treatment Group (L), Bone marrow mesenchymal stem cells Group (BMSCs) and combination of Stem cells and laser-irradiation group (BMSCs-L). Removed retainer permitted relapse. Before stem cell application or laser irradiation, each animal underwent two CBCT scans. Rat maxillae were stained with Hx&E, Masson trichrome, and tartrate-resistant acid phosphatase antibody for histology, histochemistry, and immunohistochemistry. Results and conclusionsLLLT could reduce the relapse tendency, as shown by increased bone density and enhanced remodeling of hetero-formed periodontal ligament (PDL). Furthermore, the transfer of BMMSCs on the pressure side had positive effects on PDL remodeling and decreased, but did not inhibit, the relapse rate. Finally, the synergistic effects of the application of LLLT and BMMSC were better than the control but still moderate and long-lasting. Clinical SignificanceBased on the improved relapse rate as proven in the present study, the Application of both LLLT and stem cells can be adopted to reduce the relapse tendency either lonely or collectively.